E-cigarettes and urologic health: a collaborative review of toxicology, epidemiology, and potential risks

BOURKE, Liam, BAULD, Linda, BULLEN, Christopher, CUMBERBATCH, Marcus, GIOVANNUCCI, Edward, ISLAMI, Farhad, MCROBBIE, Hayden, SILVERMAN, Debra T. and CATTO, James W.F. (2017). E-cigarettes and urologic health: a collaborative review of toxicology, epidemiology, and potential risks. European Urology, 71 (6), 915-923.

[img]
Preview
PDF
Bourke E-cigarettes and urologic health.pdf - Accepted Version
All rights reserved.

Download (752kB) | Preview
Official URL: http://europeanurology.com.marlin-prod.literatumon...
Link to published version:: https://doi.org/10.1016/j.eururo.2016.12.022
Related URLs:

    Abstract

    Context: Use of electronic cigarettes (ECs) is on the rise in most high-income countries. Smoking conventional cigarettes is a known risk factor for urologic malignancy incidence, progression, and mortality, as well as for other urologic health indicators. The potential impact of EC use on urologic health is therefore of clinical interest to the urology community. Objective: To review the available data on current EC use, including potential benefits in urologic patients, potential issues linked to toxicology of EC constituents, and how this might translate into urologic health risks. Evidence acquisition: A Medline search was carried out in August 2016 for studies reporting urologic health outcomes and EC use. Snowballing techniques were also used to identify relevant studies from recent systematic reviews. A narrative synthesis of data around EC health outcomes, toxicology, and potential use in smoking cessation and health policy was carried out. Evidence synthesis: We found no studies to date that have been specifically designed to prospectively assess urologic health risks, even in an observational setting. Generating such data would be an important contribution to the debate on the role of ECs in public health and clinical practice. There is evidence from a recent Cochrane review of RCTs that ECs can support smoking cessation. There are emerging data indicating that potentially harmful components of ECs such as tobacco-specific nitrosamines, polyaromatic hydrocarbons, and heavy metals could be linked to possible urologic health risks. Conclusions: ECs might be a useful tool to encourage cessation of conventional cigarette smoking. However, data collection around the specific impact of ECs on urologic health is needed to clarify the possible patient benefits, outcomes, and adverse events. Patient summary: While electronic cigarettes might help some people to stop smoking, their overall impact on urologic health is not clear. While electronic cigarettes might help some people to stop smoking, it is not clear if they may be bad for urologic health.

    Item Type: Article
    Research Institute, Centre or Group - Does NOT include content added after October 2018: Centre for Sport and Exercise Science
    Identification Number: https://doi.org/10.1016/j.eururo.2016.12.022
    Page Range: 915-923
    Depositing User: Carmel House
    Date Deposited: 30 Jan 2017 16:30
    Last Modified: 22 Jun 2020 15:20
    URI: http://shura.shu.ac.uk/id/eprint/15010

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics